Delivery Order SPE2DB22D2206-SPE2DB25FGF11
Award Date
3/21/25
Potential Completion Date
3/24/25
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of NEULASTA 6 MG/0.6 ML SYRINGE 0.6ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $28,718.34, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, with the ID SPE2DX15D1022|SPE2DX24FVEBJ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,275.52 firm fixed-price delivery order is for the supply of NEULASTA 6 MG/0.6 ML SYRINGE 0.6ML, with a completion date of February 28, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Both entities are...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $11,306.08, is for the delivery of Neulasta OnPro 6 mg/0.6 ml kits, a specialty medication used in the treatment of certain medical conditions. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 5, 2025. This award is not associated with a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,349.28 firm fixed-price delivery order is for the supply of the drug Neulasta OnPro, a biologic medication used to help prevent infections in cancer patients undergoing chemotherapy. The contract has an ultimate completion date of November 14, 2024 and was awarded on November 13, 2022. It...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Neulasta OnPro 6 mg/0.6 ml kits. The delivery order, valued at $7,092.23, is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $12,425.82 firm fixed price delivery order by the Defense Logistics Agency to supply NEULASTA ONPRO 6 MG/0.6 ML kits. Performance will take place in Conshohocken, Pennsylvania over a period of one day, from August 8 to August 9, 2023. The Defense Logistics Agency is the Department of Defense's combat logistics support agency, responsible for worldwide logistics support in both peacetime and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of NEUPOGEN 480 MCG/0.8 ML SYR 0.8ML. The contract has a total ceiling value of $5,293.88 and an ultimate completion date of May 10, 2024. It is a Firm Fixed Price Delivery Order contract, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of...
This federal contract award, with ID SPE2DB22D3011|SPE2DB24FQ3EH, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corporation, Corporate Office Division. The contract, valued at $1,869.74, is for the delivery of NEUPOGEN 480 MCG/1.6 ML VIAL 1.6ML, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of August 15, 2024. This award is not associated with a set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA, valued at $1,214.78, for the supply of NEUPOGEN 300 MCG/ML VIALML. This medical product is likely used to support military healthcare programs. The contract has a period of performance through February...
This federal contract award, with a ceiling value of $2,845.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...